
MHE October 2023



Laws since 1996 have sought to assure that coverage of behavioral health treatments does not take a back seat to physical medicine. Amid a national crisis in mental illness and addiction, that new world of equality has not arrived. But is it on the way?

Two drugs that target the c-MET protein are in phase 3 trials.

Payers and hospitals are at odds over proposals that would level out payments to hospital outpatient departments and physician offices.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Texas A&M researchers discover promising therapy for fatty liver disease
2
The Future of Employer Health Benefits Is Connected Care
3
FDA approves Lilly’s Onswik, the second once-weekly insulin
4
Low birth volume, finances tied to hospital obstetric unit closures
5


